Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Traumaplant for delayed onset muscle soreness
2011-004089-13Phase 2Completed
- Sponsor
- Cassella-med
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Traumaplant in delayed onset muscle soreness (DOMS) (2 arms), sponsored by Cassella-med. Primary endpoints: Pressure pain threshold change, Movement pain in upper arms and 5 more. Started Nov 2011; status: completed.
02
Drugs
Traumaplant
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on 2011-004089-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004089-13.